Resource StructureDefinition/FHIR Server from package ca.on.oh-setp#1.0.38 (78 ms)
| Package | ca.on.oh-setp |
| Type | StructureDefinition |
| Id | Id |
| FHIR Version | R4 |
| Source | https://simplifier.net/resolve?scope=ca.on.oh-setp@1.0.38&canonical=http://ontariohealth.ca/fhir/StructureDefinition/ca-on-ps-profile-medication |
| Url | http://ontariohealth.ca/fhir/StructureDefinition/ca-on-ps-profile-medication |
| Version | 0.11.0 |
| Status | active |
| Date | 2022-10-15T12:00:00+00:00 |
| Name | MedicationPSON |
| Title | Medication (PS-ON) |
| Experimental | False |
| Realm | ca |
| Description | This profile defines a set of constraints to the FHIR Medication resource for use in Ontario Patient Summaries (PS-ON). It refines constraints applied to the Medication resource by the PS-CA project to represent a medication in the patient summary. It is informed by the constraints of the [Medication-UV-IPS profile](http://hl7.org/fhir/uv/ips/StructureDefinition-Medication-uv-ips.html) and the [Canadian Baseline Profile](http://build.fhir.org/ig/HL7-Canada/ca-baseline/branches/master/StructureDefinition-profile-medication.html) to allow for cross-border and cross-jurisdiction sharing of Medication Summary information. |
| Type | Medication |
| Kind | resource |
Resources that use this resource
Resources that this resource uses
Source
{
"resourceType" : "StructureDefinition",
"id" : "ca-on-ps-profile-medication",
"url" : "http://ontariohealth.ca/fhir/StructureDefinition/ca-on-ps-profile-medication",
"version" : "0.11.0",
"name" : "MedicationPSON",
"title" : "Medication (PS-ON)",
"status" : "active",
"date" : "2022-10-15T12:00:00+00:00",
"publisher" : "Ontario Health",
"description" : "This profile defines a set of constraints to the FHIR Medication resource for use in Ontario Patient Summaries (PS-ON). It refines constraints applied to the Medication resource by the PS-CA project to represent a medication in the patient summary. It is informed by the constraints of the [Medication-UV-IPS profile](http://hl7.org/fhir/uv/ips/StructureDefinition-Medication-uv-ips.html) and the [Canadian Baseline Profile](http://build.fhir.org/ig/HL7-Canada/ca-baseline/branches/master/StructureDefinition-profile-medication.html) to allow for cross-border and cross-jurisdiction sharing of Medication Summary information.",
"fhirVersion" : "4.0.1",
"kind" : "resource",
"abstract" : false,
"type" : "Medication",
"baseDefinition" : "http://hl7.org/fhir/StructureDefinition/Medication",
"derivation" : "constraint",
"differential" : {
"element" : [
{
"id" : "Medication.meta",
"path" : "Medication.meta",
"min" : 1,
"mustSupport" : true
},
{
"id" : "Medication.meta.profile",
"path" : "Medication.meta.profile",
"min" : 1,
"mustSupport" : true
},
{
"id" : "Medication.extension:strength",
"path" : "Medication.extension",
"sliceName" : "strength",
"short" : "Extension for representing overall medication strength.",
"definition" : "The overall medication strength, rather than the strength of a specific ingredient .",
"max" : "1",
"type" : [
{
"code" : "Extension",
"profile" : [
"http://prescribeit.ca/fhir/StructureDefinition/ext-medication-strength-description"
]
}
]
},
{
"id" : "Medication.code",
"path" : "Medication.code",
"short" : "Medication that was administered or was to be administered (medication code from any code system)",
"definition" : "Medication that was administered or was to be administered. \r\n\r\nIPS-UV Note: Several kinds of medication coding could be provided as:\r\n\r\n1. The IDMP Pharmaceutical Product Identifier (PhPID), Level 1, [Substance(s)]. Example: Amoxicillin and Clavulanate Potassium; or any other equivalent coded concept;\r\n2. The IDMP Pharmaceutical Product Identifier (PhPID), Level 2 [Substance(s) + Strength + reference strength]. Example: Amoxicillin 875 mg and Clavulanate Potassium 125 mg; or any other equivalent coded concept;\r\n3. The IDMP Pharmaceutical Product Identifier (PhPID), Level 3 [Substance(s) + administrable dose form]. Example: Amoxicillin and Clavulanate Potassium, Oral Tablet; or any other equivalent coded concept;\r\n4. The IDMP Pharmaceutical Product Identifier (PhPID), Level 4 [Substance(s) + strength + reference strength + administrable dose form]. Example: Amoxicillin 875 mg and clavulanate potassium 125 mg, oral tablet; or any other equivalent coded concept 5. The IDMP Medicinal Product Identifier (MPID) or any equivalent Medicinal Product Identifier. IDMP MPID uniquely identifies a Medicinal Product, reflecting (but not replacing) any other authorization numbers allocated by a regulator. MPID implies one (set of) PhPID. The MPID shall use a common segment pattern related to a Medicinal Product, which, when each segment is valued shall define a specific MPID concept.\r\n6. The IDMP Packaged Medicinal Product Identifier (PCID) or any equivalent Packaged Medicinal Product Identifier. Uniquely identifies a Medicinal Product based on its packaging. This implies one MPID can be associated with more than one PCID, if the same Medicinal Product has more than one type of package.\r\n7. Any other kind of code that that identifies, classifies or cluster the administered product (e.g. the medicinal product or the product class)\r\n\r\nThe value sets used for the PhPID, MPID and PCID identifiers are provisional and include only few equivalent concepts used for exemplification purposes, they will be updated with real IDMP identifiers when they will become available.",
"min" : 1,
"type" : [
{
"code" : "CodeableConcept",
"profile" : [
"http://ontariohealth.ca/fhir/StructureDefinition/ca-on-ps-profile-codeableconcept"
]
}
],
"example" : [
{
"label" : "DIN",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/NamingSystem/ca-hc-din",
"code" : "02247611",
"display" : "Acetaminophen 325mg (Jamieson Laboratories Ltd.)"
}
],
"text" : "ACETAMINOPHEN 325MG"
}
},
{
"label" : "NPN",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-hc-npn",
"code" : "80016551",
"display" : "Echinacea with Garlic and Ginger (Jamieson Laboratories Ltd.)"
}
],
"text" : "Echinacea with Garlic and Ginger"
}
},
{
"label" : "CCDD",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://fhir.infoway-inforoute.ca/CodeSystem/canadianclinicaldrugdataset",
"code" : "02240105",
"display" : "AVEENO ANTI-ITCH LOTION (calamine 3 % and pramoxine hydrochloride 1 % lotion) JOHNSON & JOHNSON INC"
}
],
"text" : "Aveeno Anti-Itch Lotion"
}
}
],
"mustSupport" : true,
"binding" : {
"strength" : "preferred",
"description" : "Canadian Clinical Drug Data Set codes",
"valueSet" : "https://fhir.infoway-inforoute.ca/ValueSet/prescriptionmedicinalproduct"
}
},
{
"id" : "Medication.code.coding",
"path" : "Medication.code.coding",
"slicing" : {
"discriminator" : [
{
"type" : "pattern",
"path" : "$this"
}
],
"description" : "Discriminated by value set",
"rules" : "open"
},
"mustSupport" : true
},
{
"id" : "Medication.code.coding.display.extension:translation",
"path" : "Medication.code.coding.display.extension",
"sliceName" : "translation"
},
{
"id" : "Medication.code.coding.display.extension:translation.extension",
"path" : "Medication.code.coding.display.extension.extension",
"min" : 2
},
{
"id" : "Medication.code.coding:atcClass",
"path" : "Medication.code.coding",
"sliceName" : "atcClass",
"short" : "Optional slice for representing WHO ATC classification",
"definition" : "WHO ATC classification",
"binding" : {
"strength" : "required",
"valueSet" : "http://hl7.org/fhir/uv/ips/ValueSet/whoatc-uv-ips"
}
},
{
"id" : "Medication.code.coding:atcClass.display.extension:translation",
"path" : "Medication.code.coding.display.extension",
"sliceName" : "translation"
},
{
"id" : "Medication.code.coding:atcClass.display.extension:translation.extension",
"path" : "Medication.code.coding.display.extension.extension",
"min" : 2
},
{
"id" : "Medication.code.coding:codeSCT",
"path" : "Medication.code.coding",
"sliceName" : "codeSCT",
"short" : "Optional slice for representing SNOMED CT medications",
"definition" : "SNOMED CT medications (Pharmaceutical / biologic product)",
"binding" : {
"strength" : "required",
"valueSet" : "http://hl7.org/fhir/uv/ips/ValueSet/medication-snomed-uv-ips"
}
},
{
"id" : "Medication.code.coding:codeSCT.display.extension:translation",
"path" : "Medication.code.coding.display.extension",
"sliceName" : "translation"
},
{
"id" : "Medication.code.coding:codeSCT.display.extension:translation.extension",
"path" : "Medication.code.coding.display.extension.extension",
"min" : 2
},
{
"id" : "Medication.code.coding:codeCCDD",
"path" : "Medication.code.coding",
"sliceName" : "codeCCDD",
"short" : "Slice for representing Canadian Clinical Drug Data Set codes",
"definition" : "Value set consisting of all Manufactured Product (MP), Non-proprietary Therapeutic Product (NTP) and Therapeutic Moiety (TM) codes, which would be created and maintained by Canada Health Infoway. Medicinal products for prescribing and dispensing in Canada. The content of this subset only contains commonly used medicinal products that are available for prescribing and dispensing in Canada. This content will expand to include all human medicinal products over time.",
"mustSupport" : true,
"binding" : {
"strength" : "required",
"valueSet" : "https://fhir.infoway-inforoute.ca/ValueSet/prescriptionmedicinalproduct"
}
},
{
"id" : "Medication.code.coding:codeCCDD.display.extension:translation",
"path" : "Medication.code.coding.display.extension",
"sliceName" : "translation"
},
{
"id" : "Medication.code.coding:codeCCDD.display.extension:translation.extension",
"path" : "Medication.code.coding.display.extension.extension",
"min" : 2
},
{
"id" : "Medication.code.coding:codeLNHP",
"path" : "Medication.code.coding",
"sliceName" : "codeLNHP",
"short" : "Optional slice for representing NPN and DIN-HM codes in the Licensed Natural Health Products Database",
"definition" : "Value set consisting of all Natural Product Number (NPN) and Homepathic Medicine Number (DIN-HM) codes that are licensed by Health Canada and present in the Licensed Natural Health Products Database.",
"binding" : {
"strength" : "required",
"valueSet" : "http://fhir.infoway-inforoute.ca/io/psca/ValueSet/LicensedNaturalHealthProducts"
}
},
{
"id" : "Medication.code.coding:codeLNHP.display.extension:translation",
"path" : "Medication.code.coding.display.extension",
"sliceName" : "translation"
},
{
"id" : "Medication.code.coding:codeLNHP.display.extension:translation.extension",
"path" : "Medication.code.coding.display.extension.extension",
"min" : 2
},
{
"id" : "Medication.form",
"path" : "Medication.form",
"definition" : "Describes the form of the item. Powder; tablets; capsule.\r\n\r\nAdministrable Pharmaceutical Dose Form. \r\nThis code represents the form of the medication (e.g. tablet, capsule, liquid)\r\n\r\nSince the EDQM Standards Terms, together with UCUM, is one of the IDMP terminologies actually available for usage, this code system has been selected as reference terminology for representing Pharmaceutical Dose forms; Packages and Route of Administration.\r\n\r\n Alternative jurisdictional and international terminologies are known to be used for this concept domain, such as NCI or SNOMED CT.",
"comment" : "Work is underway to define the pan-Canadian terminology that will be preferred and/or socialized for this element.",
"type" : [
{
"code" : "CodeableConcept",
"profile" : [
"http://ontariohealth.ca/fhir/StructureDefinition/ca-on-ps-profile-codeableconcept"
]
}
],
"mustSupport" : true,
"binding" : {
"strength" : "preferred",
"description" : "SCTCA Pharmaceutical Dose Form",
"valueSet" : "https://fhir.infoway-inforoute.ca/ValueSet/pharmaceuticaldoseformcode"
}
},
{
"id" : "Medication.form.coding",
"path" : "Medication.form.coding",
"slicing" : {
"discriminator" : [
{
"type" : "pattern",
"path" : "$this"
}
],
"description" : "Discriminated by value set",
"rules" : "open"
},
"mustSupport" : true
},
{
"id" : "Medication.form.coding.display.extension:translation",
"path" : "Medication.form.coding.display.extension",
"sliceName" : "translation"
},
{
"id" : "Medication.form.coding.display.extension:translation.extension",
"path" : "Medication.form.coding.display.extension.extension",
"min" : 2
},
{
"id" : "Medication.form.coding:formSCTCA",
"path" : "Medication.form.coding",
"sliceName" : "formSCTCA",
"short" : "Optional slice for representing SNOMED CT Canadian edition dose forms",
"definition" : "SNOMED CT Canadian edition dose forms",
"binding" : {
"strength" : "required",
"valueSet" : "https://fhir.infoway-inforoute.ca/ValueSet/pharmaceuticaldoseformcode"
}
},
{
"id" : "Medication.form.coding:formSCTCA.display.extension:translation",
"path" : "Medication.form.coding.display.extension",
"sliceName" : "translation"
},
{
"id" : "Medication.form.coding:formSCTCA.display.extension:translation.extension",
"path" : "Medication.form.coding.display.extension.extension",
"min" : 2
},
{
"id" : "Medication.ingredient",
"path" : "Medication.ingredient",
"mustSupport" : true
},
{
"id" : "Medication.ingredient.item[x]",
"path" : "Medication.ingredient.item[x]",
"slicing" : {
"discriminator" : [
{
"type" : "type",
"path" : "$this"
}
],
"ordered" : false,
"rules" : "open"
}
},
{
"id" : "Medication.ingredient.item[x]:itemCodeableConcept",
"path" : "Medication.ingredient.item[x]",
"sliceName" : "itemCodeableConcept",
"comment" : "IPS UV Note: The IDMP ISO 11238 standard addresses the identification and exchange of regulated information on substances. \\n The Global Ingredient Archival System (GInAS) will provide a common global identifier for all of the substances used in medicinal products, providing a definition of substances globally consistent with this standard.\\n Those identifiers however are yet available for concrete usage, therefore in this version of the template, SNOMED CT has been chosen as reference terminology also for the active substances.\\n This choice will be revised based on the availability and the maturity of GInAS.",
"type" : [
{
"code" : "CodeableConcept",
"profile" : [
"http://ontariohealth.ca/fhir/StructureDefinition/ca-on-ps-profile-codeableconcept"
]
}
],
"mustSupport" : true,
"binding" : {
"strength" : "preferred",
"description" : "SNOMED CT CA drug substances",
"valueSet" : "https://fhir.infoway-inforoute.ca/ValueSet/drugormedicamentsubstancecode"
}
},
{
"id" : "Medication.ingredient.item[x]:itemCodeableConcept.coding",
"path" : "Medication.ingredient.item[x].coding",
"slicing" : {
"discriminator" : [
{
"type" : "pattern",
"path" : "$this"
}
],
"description" : "Discriminated by value set",
"rules" : "open"
},
"mustSupport" : true
},
{
"id" : "Medication.ingredient.item[x]:itemCodeableConcept.coding.display.extension:translation",
"path" : "Medication.ingredient.item[x].coding.display.extension",
"sliceName" : "translation"
},
{
"id" : "Medication.ingredient.item[x]:itemCodeableConcept.coding.display.extension:translation.extension",
"path" : "Medication.ingredient.item[x].coding.display.extension.extension",
"min" : 2
},
{
"id" : "Medication.ingredient.item[x]:itemCodeableConcept.coding:ingredientSCTCA",
"path" : "Medication.ingredient.item[x].coding",
"sliceName" : "ingredientSCTCA",
"short" : "Optional slice for representing SNOMED CT Canadian edition drug active substances",
"definition" : "SNOMED CT Canadian edition drug active substances",
"mustSupport" : true,
"binding" : {
"strength" : "required",
"valueSet" : "https://fhir.infoway-inforoute.ca/ValueSet/drugormedicamentsubstancecode"
}
},
{
"id" : "Medication.ingredient.item[x]:itemCodeableConcept.coding:ingredientSCTCA.display.extension:translation",
"path" : "Medication.ingredient.item[x].coding.display.extension",
"sliceName" : "translation"
},
{
"id" : "Medication.ingredient.item[x]:itemCodeableConcept.coding:ingredientSCTCA.display.extension:translation.extension",
"path" : "Medication.ingredient.item[x].coding.display.extension.extension",
"min" : 2
},
{
"id" : "Medication.ingredient.strength",
"path" : "Medication.ingredient.strength",
"type" : [
{
"code" : "Ratio",
"profile" : [
"http://ontariohealth.ca/fhir/StructureDefinition/ca-on-ps-profile-ratio"
]
}
],
"mustSupport" : true
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.
FHIR